This study investigated the relationship between host efflux system of the non-vertebrate nematode Caenorhabditis elegans and Burkholderia cepacia complex (Bcc) strain virulence. This is the first comprehensive effort to profile host-transporters within the context of Bcc infection. With this aim, two different toxicity tests were performed: a slow killing assay that monitors mortality of the host by intestinal colonization and a fast killing assay that assesses production of toxins. A Virulence Ranking scheme was defined, that expressed the toxicity of the Bcc panel members, based on the percentage of surviving worms. According to this ranking the 18 Bcc strains were divided in 4 distinct groups. Only the Cystic Fibrosis isolated strains possessed profound nematode killing ability to accumulate in worms’ intestines. For the transporter analysis a complete set of isogenic nematode single Multidrug Resistance associated Protein (MRP) efflux mutants and a number of efflux inhibitors were interrogated in the host toxicity assays. The Bcc pathogenicity profile of the 7 isogenic C. elegans MRP knock-out strains functionality was classified in two distinct groups. Disabling host transporters enhanced nematode mortality more than 50% in 5 out of 7 mutants when compared to wild type. In particular mrp-2 was the most susceptible phenotype with increased mortality for 13 out 18 Bcc strains, whereas mrp-3 and mrp-4 knock-outs had lower mortality rates, suggesting a different role in toxin-substrate recognition. The use of MRP efflux inhibitors in the assays resulted in substantially increased (>40% on average) mortality of wild-type worms.
Citation: Tedesco P, Visone M, Parrilli E, Tutino ML, Perrin E, Maida I, et al. (2015) Investigating the Role of the Host Multidrug Resistance Associated Protein Transporter Family in Burkholderia cepacia Complex Pathogenicity Using a Caenorhabditis elegans Infection Model. PLoS ONE 10(11): e0142883. https://doi.org/10.1371/journal.pone.0142883
Editor: Denis Dupuy, Inserm U869, FRANCE
Received: July 15, 2015; Accepted: October 28, 2015; Published: November 20, 2015
Copyright: © 2015 Tedesco et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: Data underlying the findings described in the manuscript are freely available to other researchers and they are in the body of the manuscript.
Funding: This work was supported by the EU-KBBE 2012-2016 project PharmaSea, grant N° 312184. Elena Perrin is financially supported by a “Fondazione Adriano Buzzati-Traverso” fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
The Burkholderia cepacia complex (Bcc) occupies a critical position among Gram-negative multi-drug resistant bacteria. It consists of at least 20 closely related species inhabiting different ecological niches, including plants and animals [1–5]. Bcc multi drug and pandrug-resistant opportunistic human pathogens cause problematic lung infections in immune-compromised individuals, including cystic fibrosis (CF) patients [6–8]. Bcc members are naturally resistant to antibiotics including cephalosporins, β-lactams, polymyxins and aminoglycosides, rendering Bcc infections challenging to eradicate [9,10]. There is an imminent need to develop new Bcc antimicrobial therapeutic strategies. Dissecting virulence and pathogenicity determinants as well as identifying novel therapeutic targets may be promising approaches. These tasks may be advanced by the exploitation of the non-vertebrate host models Drosophila melanogaster, Galleria mellonella, and Caenorhabditis elegans. Model hosts have been used to evaluate microbial virulence traits involved in mammalian infections and the efficacy of antimicrobial compounds [11–16]. The free-living nematode C. elegans is a widespread multicellular organism that is a self-fertilizing hermaphrodite with a rapid generation time. C. elegans has been proven cost-effective, ethical, reproducible and genetically powerful infection model despite the obvious reported technical limitations (nematodes have lower optimal growth temperatures when compared with human pathogens; occurrence of host specific virulence factors) [15,17–19]. In fact, there is an extensive body of literature for the utility of the nematode to model infection with a variety of Gram-negative bacteria including Escherichia coli, Burkholderia pseudomallei, B. cepacia complex and Pseudomonas aeruginosa [20–23]. The C. elegans-Bcc studies in the last decade have shed some light on the complex-nematode interaction, correlating genotypic characteristics of the pathogen with phenotypic changes in the host. These efforts have identified specific virulence factors: the auto inducer dependent Acyl-HomeSerineLactone (aidA), the phenazine biosynthesis regulator (Pbr), and the host factor phage Q, (hfq) [16,24–33].
Recent studies have underlined the importance of efflux systems in infection within the content of host-pathogen interaction [34–36]. The host efflux capability is considered part of a basic defence mechanism. For example the B. pseudomallei infection stimulates the overproduction of the ATP Binding Cassette (ABC) transporter pgp-5 in C. elegans . However, the partition of host transporters in the infection process has never been studied in depth. Bcc members produce a variety of metabolites and toxins, potential host efflux substrates. Furthermore, exploring the role of host transporters in pathogenicity may facilitate the design of appropriate tools for toxin identification. Multidrug Resistance associated Proteins (MRPs) are members of the ABC efflux transporter family with broad substrate specificity for the transport of endogenous and xenobiotic anionic substances found in Bacteria, Archaea and Eukarya [38–41]. MRPs play important roles in nematode physiology such as control resistance to anthelmintic (ivermectine) and heavy metals (arsenic) [42–44]. This study emphasizes the contribution of the host MRP efflux subfamily to Bcc virulence, employing a panel of 18 strains representing the up-to-date different acknowledged species and a fully functional seven single C. elegans mutant set impaired in MRPs. A Virulence-Ranking (VR) scheme based on comparing host survival rates in two different assays was developed. This scheme provides the tool for a detailed study on the effect of the MRP transporter family on Bcc virulence using as well as selected efflux inhibitors.
Materials and Methods
Bacterial strains, nematode strains and growth conditions
C. elegans Wild-type (WT) Bristol N2, NL147 (mrp-1(pk89) X), RB1713 (mrp-2(ok2157) X), RB1028 (mrp-3(ok955) X), VC712 (mrp-4(ok1095) X), VC1599 (mrp-5(ok2067)/szT1 X), RB1070 (mrp-6(ok1027) X) and RB1269 (mrp-8(ok1360) III) strains were obtained from the Caenorhabditis Genetic Centre (CGC). For strain VC1599, due to ok2067 mutation lethality in homozygosis, all the experiments were performed assaying heterozygotes worms. All mutants presented identical phenotypic traits in respect to WT: normal larval development (eggs reaching adults state in 72 h as indicated on standard table (www.wormbook.org)), non-impaired reproduction, and survival rate at 100% when fed with E. coli. Mutant mpr-5 in heterozygosis also aligned to those parameters. All strains were recovered from frozen stocks, and routinely kept on NGM (Nematode Growth Medium) plates seeded with E. coli OP50 as a food source . The panel of Bcc strains used in this work belongs to the Bcc collection at the University of Gent, Belgium, and is listed in Table 1. Bcc and E. coli OP50 cells were routinely grown in Luria-Bertani broth (LB) (10 g/L Bacto-tryptone, 5 g/L Yeast extract, 10 g/L NaCl) at 37°C.
Nematode Toxicity Assays
Slow Killing Assay (SKA) was performed against the C. elegans WT strain N and MRP-mutants. 2.5-cm-diameter plates containing 3 ml of NGM agar (Peptone 2.5 g/L, NaCl 2,9 g/L, Bacto-Agar 17 g/L, CaCl2 1 mM, Cholesterol 5 μg/mL, KH2PO4 25 mM, MgSO4 1 mM) were seeded with 50 μl of the overnight Bcc cultures, normalized to an OD600, of 1.7 and incubated for 24 h at 37°C to allow the formation of a bacterial lawn. This was the standard bacterial growth condition unless otherwise stated. C. elegans WT strain and MRP-mutants were synchronized by bleaching treatment , and 30–40 worms at larval stage 4 (L4), were transferred to each plate and incubated at 20°C for three days. The plates were scored for living worms every 24 h.
Fast Killing assay (FKA) was carried out in 2.5-cm-diameter plates containing 3 ml of Peptone Glucose Sorbitol (PGS) agar medium  (Peptone 12 g/L, Glucose 12 g/L, Sorbitol 27.25 g/L, NaCl 12 g/L, Bacto-Agar 17 g/L, CaCl2 1 mM, Cholesterol 5 μg/mL, KH2PO4 25 mM, MgSO4 1 mM). Plates were prepared as described above for the SKA. Then, L4 worms from WT strain and MRP-mutants were collected from NGM plates, washed with M9 medium (Na2HPO4·7H2O 12.8 g/L, Na2HPO4 (anhydrous) 6 g/L, KH2PO4 3 g/L, NaCl 0.5 g/L, NH4Cl 1 g/L) and 30–40 L4 worms were spotted onto the bacterial lawn. The plates were then incubated at 20°C and scored for living worms every 24 h. In both assays, E. coli OP50 was used as a negative control. A worm was considered dead when it no longer responded to touch. For statistical purposes, 5 replicates per trial were carried out with a unique egg preparation. The incubation time was set at 2 days. A pathogenicity scheme (VR) was established by comparing the "infectivity" towards nematodes between E. coli OP50 and Bcc isolates.
40–60 WT L4 worms were grown on NGM plates seeded with Bcc or E. coli OP50 propagated in standard growth conditions. Plates were incubated at 20°C, and after 4 and 24 h, the nematodes were inspected using a Zeiss Axioskop microscope equipped with Differential Interference Contrast (DIC) employing 10x, 20x, 40x, 63x and 100x objectives and 10X eyepiece. Images were collected with a Zeiss Axiocam MR digital camera.
Toxin Diffusion assay
Bcc or E. coli OP50 cells were grown under standard growth conditions and spread on sterile 0.22 μm Millipore Nitrocellulose (Darmstadt, Germany) filter disk located onto 2.5-cm-diameter PGS plates . After overnight incubation at 37°C, the filter together with the bacterial lawn was removed and the plates were allowed to cool to room temperature. 30–40 hypochlorite-synchronised WT L4 nematodes were spotted onto the conditioned agar. Paralysation and mortality of the worms were detected at 4 and 24 h. The experiments were performed in triplicate, and data reported are mean values ± SD.
Statistical analysis and clustering
All the Kaplan-Meier survival curves were analyzed using the Graph-pad Prism 5 software. Comparisons vs. control for both the C. elegans and inhibitor experiments were performed using Fisher’s exact test to account for possible non-Normality in the data. In particular, as it was observed that replicate means of C. elegans percent mortality correlated extremely well to pooled percent mortality (R2 > 0.99 in all cases), counts of C. elegans that were alive and dead after 72 h were used to populate the various 2x2 tables onto which the Fisher’s exact test was applied. Bonferroni-Holm correction of p-values was used to account for the multiple comparisons performed.
Mutant clustering analysis was performed using hierarchical clustering via Ward’s method. Clusters were fixed using a consistency threshold of 1.1, resulting in cophenetic coefficient (correlation between cluster and metric distance) of at least 0.80.
Transporter Inhibitor assays
The MRP transporter inhibitors mometasone furoate, lasalocid A sodium, verapamil hydrochloride were purchased from Sigma-Aldrich, Saint Louis, MO. Compounds were dissolved in DMSO and spread onto NGM plates in different concentration ranges: 25–100 μM (mometasone and verapamil) and 125–500 nM (lasalocid). DMSO (0,5% w/v) was used as control. Subsequently, Bcc strains (grown in standard conditions) were spotted onto the plates that were incubated overnight at 37°C. After the incubation 30–40 WT L4 worms were spotted onto the bacterial lawn. The plates were then incubated at 20°C for 3 days and scored for living worms every 24 h. The experiments were performed in triplicate, and the data reported are mean values.
Results and Discussion
Killing of C. elegans by Bcc strains
To evaluate Bcc virulence determinants and properties, two different assays were performed: i) SKA, performed on a low osmolarity medium (NGM), assigned to correlate worms mortality with intestinal bacterial accumulation/colonisation [24,25]; ii) FKA carried out on a high osmolarity medium (PGS) to demonstrate the secretion of bacterial toxins and evaluate their capacity to paralyse and kill the nematodes [24,25]. A VR was established for the Bcc strains under investigation by comparing the "infectivity" against nematodes between E. coli OP50 and Bcc isolates. The VR ranges from 0 to 3 (see Fig 1) and was based on the percentage of surviving worms after the period of observation, which was set at 3 days. A Bcc strain was considered to be non-pathogenic (VR = 0) when no symptom of disease was observed during the course of nematodes infection and the percentage of live worms at the conclusion of the period of observation ranged from 100 to 80%; VR = 1 corresponded to a percentage of alive worms between 79 to 50%; VR = 2 corresponded to a percentage of alive worms between 49 to 6%; finally, the VR was considered 3 when the percentage of surviving worms was ≤ 5%.
Worms fed on: B. metallica (VR 3; black line; n = 113; 0% survival at day 2); B. seminalis (VR 2; blue line; n = 150; 34% survival at day 2); B. dolosa (VR 1; redline; n = 198; 69% survival at day 2); B. multivorans (VR 0; green line; n = 120; 93% survival worms). n: Number of worms at day 0. All p-values, comparing each survival curve between them, resulted to be < 0.0001, calculated with "Log-rank (Mantel-Cox) Test" with the Graph-pad Prism 5 software.
SKA performed against WT L4 worms revealed diverse pathogenicity capabilities among the 18 Bcc representatives [Table 1]:
- 2 Bcc strains (B. metallica, B. stabilis) displayed high nematocide activity (VR 3). No viable nematodes were detectable in the plates after 3 days of incubation at 20°C.
- Half of the Bcc strains exhibited VR between 1 and 2, showing an intermediate toxicity towards C. elegans.
- Seven Bcc strains (B. ambifaria, B. cepacia, B. dolosa, B. pseudomultivorans, B. pyrrocinia, B. lata and B. multivorans) were unable to kill worms, and the whole population was viable (VR = 0).
Nematodes killed in the lawn of bacteria took on a ghostly and hollow “shell-like” appearance about 48 h after the L4 were first introduced, and their shells induced by B. ubonensis, B. metallica and B. stabilis were defined as “chalk-mark ghosts”. This shape is characteristic of organisms lacking a discernible internal cell structures. Often the ghosts eroded to a mere outline.
The pathogenicity of the 18 Bcc strains was then assessed on FKA. Data obtained are summarised in Table 1. Nematodes death on FKA appeared to be a rapid process as they loose locomotor functions, as shown by the quick onset of lethargy. Motility visibly decreased after exposure for 4 h, and the rate of foraging was similarly affected in the same time frame. In FKA, five strains (B. ambifaria, B. cepacia, B. contaminans, B. metallica, B. stabilis) demonstrated deep killing ability (VR = 3) against C. elegans and only two strains (B. multivorans and B. vietnamiensis) were completely ineffective in killing worms. For the highly active strains, almost 100% mortality occurred in 24 h, while on SKA 3 days are required for complete killing (Fig 2).
A) The pathogenicity of Bcc strain B. cepacia on SKA (n = 93) was compared with the ability on FKA (n = 184). B) The pathogenicity of Bcc strain B. metallica on SKA (n = 80) was compared with the ability on FKA (n = 113). C) The pathogenicity of Bcc strain B. stabilis on SKA (n = 87) was compared with the ability on FKA (n = 161). P-values were calculated between survival curves on FKA and SKA of each bacteria, and resulted to be < 0.0001 calculated with "Log-rank (Mantel-Cox) Test" with the Graph-pad Prism 5 software.
Nine out of 18 Bcc strains have previously been characterized using SKA [30,47]. The VR of 7 strains (B. anthina, B. ubonensis, B. vietnamiensis, B. cenocepacia B. dolosa B. ambifaria, B. cepacia) are consistent with the previously reported SKA ranking. The same comparison revealed a variation for B. pyrrocinia and B. stabilis, which were found as more and less virulent, respectively. This variability may be due to ranking differences, as the experimental conditions were very reproducible. This is the first report for an indicative pathogenicity ranking for 8 Burkholderia species, recently added to Bcc, (B. latens, B. diffusa, B. arboris, B. seminalis, B. metallica, B. pseudomultivorans, B. lata, B. contaminans). B. metallica, B. stabilis (both isolated from CF patients) were the most virulent in both assays (Fig 2B and 2C). The comparison of data obtained in the FKA and SKA revealed that, on average, strains isolated from CF patients appeared more virulent than environmental isolates on SKA. In particular, three Bcc strains (B. ambifaria, B. cepacia and B. pyrrocinia) exhibited high nematocide activity in the FKA, whereas they were unable to kill the worms in the SKA (VR 0 and 1). Therefore we can assume that toxin production is a common virulence mechanism for Bcc members, while CF isolates might have acquired different pathogenic traits that allow them to infect and colonize hosts, as already proposed by Pirone et al. . The only exception is represented by B. multivorans, and B. pseudomultivorans. These two strains are CF isolates, but were non-virulent towards nematodes. This evidence likely rely in the limitation of the nematode host model, once more indicating that virulence factors are not universal for all hosts .
Bacterial intestinal accumulation.
The two Bcc strains with VR = 3 in the SKA (B. stabilis and B. metallica) were then assessed for their ability to accumulate in the C. elegans intestine. Worms grown in standard condition were inspected using a compound microscope at different incubation times to evaluate the bacterial accumulation in the intestinal lumen.
Bcc colonization of nematode occurred rapidly. After 4 h of incubation, worms fed with E. coli OP50 showed a thin intestinal lumen (Fig 3A and 3B), whereas, when spotted onto B. metallica layer, worms already presented deformed intestines (Fig 3E). After 24 h nematodes displayed a full intestinal lumen packed with bacteria (Fig 3F). These data confirmed that Bcc with high VR were able to accumulate within the entire nematode intestine and therefore slow-killing may resemble an infection-like process. On the contrary, nematodes exposed to the strain B. pseudomultivorans, which exhibited a low pathogenicity (VR = 0 on SKA), under the same experimental conditions presented a healthy intestine with the presence of bacterial cells only in the first part of the intestine (Fig 3C and 3D). This finding may signify that: i) even non-pathogenic Bcc strains were able to pass intact through the pharynx and occupy the intestine; ii) the accumulation of the Bcc in the whole nematode gut, especially in the last part of the intestine, might be responsible for the worm’s death .
Red arrows indicate the nematodes intestine. A) Intestinal lumen of one L4 stage WT worm after 4 h of incubation on NGM plate spotted with E. coli OP50, and B) after 24 h of incubation on the same plate. C) Intestinal lumen of one L4 WT after 4 h of incubation on NGM plate spotted with B. pseudomultivorans (VR 0 on SKA, and D) after 24 h of incubation on the same plate. E) Intestinal lumen of one L4 WT after 4 h of incubation on NGM plate spotted with B. metallica (VR 3 on SKA, and F) after 24 h of incubation on the same plate.
Toxin Diffusion assay.
To evaluate the contribution of diffusible secreted factors (toxins and/or other virulence chemical signalling molecules) to the rapid kinetics of killing on FKA, we performed the toxin diffusion assay . These experiments were carried out on a reduced panel consisting of the five Bcc strains possessing the highest nematocide activity on FKA (B. contaminans, B. cepacia, B. ambifaria, B. metallica and B. stabilis). Results shown in Fig 4 revealed that a high percentage of worms were paralyzed after 4 h of incubation on plates, even if they were not in contact with the bacteria. In particular, only 30% of the worms placed on B. ambifaria plates were still mobile and active, whereas the remaining nematode population appeared paralysed. On the contrary, worms spotted on plates containing E. coli conditioned agar did not present any paralysis or mortality. Among the tested Bcc strains, B. ambifaria was the most active toxin producer. Indeed, after 24 h of incubation only 20% of the total number of nematodes was still moving on B. ambifaria plates (Fig 4). In the case of B. stabilis, it was observed that paralyzed worms at 4 h were able to move again and survive. One plausible explanation for this variation might be related to low stability of the diffusible toxins/virulence determinants produced by those strains that require constant production.
Data reports paralysis and mortality at 4 and 24 h of worms plated on PGS medium plates treated with Bcc strains or E. coli grown on a sterile disk. Data represent mean values of three independent experiments and SD values are reported. P-values were calculated between sample (Bcc) and control (OP50) at the corresponding time, and were always < 0.05.
Interestingly, when the toxin filter assay was performed on NGM medium, no paralysis or mortality was detected. This experiment confirms that FKA rapid killing kinetics revealed a role for diffusible toxins as a main component of the infectious process. Thomson and Dennis demonstrated the production by Bcc strains of a haemolytic toxin required for full virulence, synthesized by a non-ribosomal peptide synthase (NRPS) pathway, typical of a complex secondary metabolite . They screened a panel of Bcc strains including B. cenocepacia, B. stabilis, B. pyrrocinia and B. vietnamiensis for the presence of this gene cluster. A NRPS cluster was identified in B. pyrrocinia and B. stabilis with VR = 3 on FKA. Moreover, Bcc strains are known to produce toxins with demonstrated antifungal activity like the cyclic peptides occidiofungins (burkholdines) . Therefore, we cannot a priori exclude the possibility that a peptide might represent the toxin active towards C. elegans.
Killing of MRPs knock-out C. elegans mutants by Bcc member strains
The nematode-Bcc pathogenicity ranking system developed was investigated for its ability to detect and map genotype-specific host responses. We obtained access to a complete, seven MRPs knock-out nematode mutant set, mrp-1(pk89), mrp-2(ok2157), mrp-3(ok955), mrp-4(ok1095), mrp-5(ok2067), mrp-6(ok1027) and mrp-8(ok1360), impaired in the corresponding ABC membrane transporters.
These knock-out mutants exhibited identical phenotypic attributes with the WT. The 18 Bcc representative strains were profiled against the 7 mutants in both SKA and FKA. Control mortality was calculated to be the number of dead worms divided by the number of total worms. Pooled mortality counts (alive vs. dead) for each mutant were tested against the WT using Fisher’s Exact test. Statistically significant (Bonferroni-Holm corrected p-value < 0.05) differences from WT are shown in Table 2. The mortality rates calculated were highly variable suggesting a Bcc strain-specific effect towards the MRP C. elegans mutants. Some trends were detected: mrp-5 and mrp-2 had increased mortality rate for several Bcc strains in both SKA and FKA. Specifically, 8 Bcc strains in SKA and 9 in FKA showed increased killing towards mrp-5, while 8 strains in SKA and 8 in FKA appeared more virulent against mrp-2. C. elegans mutants mrp-3 and mrp-4 displayed lower killing rates when incubated with several Bcc strains. In particular, mutant mrp-4 exhibited decreased mortality to 8 Bcc species in SKA and to 7 strains in FKA. Regarding the Bcc strains, on SKA B. ambifaria displayed increased virulence towards the whole mutant set, with mortality rate compared to the WT higher than 75% and 71% towards, mrp-5 and mrp-6 respectively. B. arboris demonstrated an increased pathogenic effect towards mrp-1, mrp-2, mrp-6, mrp-8, while B. dolosa was more lethal against mrp-2, mrp-5, mrp-6, mrp-8 mutants. On FKA, B. lata and B. multivorans were the most pathogenic strains with increased mortality rate against all mutants, while B. diffusa was more virulent against 6 mutants, and B. arboris against 5 mutants.
Mutant mrp-5 was tested as heterozygote, due to lethality of the mutation in homozygosis. Statistical significant differences appear highlighted, with negative values indicating statistically significant reductions in mortality from WT, and with positive values indicating statistically significant increases in mortality from WT.
The complete set of killing results for each Bcc strain generated a unique killing profile in each MRP mutant. To determine whether these profiles constitute a coherent mutant classification pattern, a hierarchical clustering of significant effect sizes vs. each strain (Ward’s method, Consistency Threshold 1.1) was performed. This analysis showed different patterns for mrp-3 and mrp-4 when compared with the rest of MRP-phenotypes in both FKA and SKA. However, mrp-3 and mrp-4 share low sequence identity/similarity among them (data not shown), suggesting that these two transporters do not have similar substrate specificity or function. These MRP-phenotypes were grouped consistently and differentiated from the rest of single knock out strains (Fig 5). This pattern could justify the diverse phenotypic response to Bcc of the MRP knock-out mutants, indicating variation in substrate profile specificity for the 7 MRP efflux systems. The clustering patterns of the other transporters suggest distinct substrate specificity, in agreement with the low degree of sequence identity/similarity shared among them (data not shown). Nevertheless, we can assume that toxins and small molecules are MRP-related substrates, and these transporters play a fundamental role in Bcc defence, with the exception of mrp-3 and mpr-4.
The Bcc pathogenicity ranking system was used to facilitate testing for a distinct MRP-efflux system substrate profile within the content of infection. Disabling efflux pumps genetically (knock-outs) or chemically (small molecules-inhibitors) should have a similar toll on increasing nematode mortality. A pilot analysis was performed utilizing the Bcc strains that exhibited increased C. elegans susceptibility in numerous efflux knock-outs on SKA (B. ambifaria, B. arboris, B. cepacia, B. dolosa, B. pyrrocinia) and the well-characterized mammalian MRP-efflux inhibitors mometasone furoate, lasalocid A and verapamil . All compounds did not affect Bcc or C. elegans viability at the concentration used for the assay, (S1 Fig) The compounds were spread in concentration ranges onto NGM plates to perform SKA and DMSO (0.5%) was used as a growth control. Control mortality was calculated to be the number of dead worms divided by the number of total worms. Comparison to solvent control of pooled mortality counts was done using Fisher’s Exact test; results were considered significant if Bonferroni-Holm corrected p-values were less than 0.05. Statistically significant differences from the WT are shown in Table 3. Reduction in mortality from the controls was not observed. The inhibitor use in the infection system, provided a statistically significant increase of mortality in the presence of at least one inhibitor compared to DMSO controls for 3 Bcc strains, whereas B. pyrrocinia and B. ambifaria killing rates were not affected.
Nematodes mortality expressed as percentage of dead worms and compared between samples with inhibitors and control with DMSO (0,5%). Statistical significant differences were reported.
In particular, the presence of mometasone (100 μM), B. arboris, B. cepacia and B. dolosa enhanced virulence against nematodes with mortality rate of 40% higher than the control. Lasalocid (500 nM) caused an increase in the percentage of dead worms of 34% and 48% with B. cepacia and B. dolosa, respectively. Verapamil (100 μM) enhanced killing only for B. arboris, with a killing rate of 35% higher than the control. These results demonstrated that the inhibitor driven MRP transporter inactivation results in increased mortality at least for two inhibitors, of the nematodes to Bcc strains, supporting the role of these transporters in Bcc infection. Verapamil has been characterized as a competitive inhibitor in ABCB1 malignant cell overexpression  as wells as a potent ABCC family inhibitor . It is also involved in inhibiting C. elegans P-gp1, which is involved in nematode resistance to ivermectine . The present experimental setup differs as it explores verapamil against a number of targets simultaneously not by isolating transporters of interest. This analysis suggests that verapamil very likely works, but the number of interactions leading to a weaker phenotype should be investigated further.
The major aim of this work was to inquire the role of host transporters in the infection developing a nematode virulence ranking system focusing in well-recognized Bcc strains. It is common knowledge that every bacterial species includes member-strains with different pathogenic characteristics. However, the key purpose was to build the model using type strains of each of the 18 currently known Bcc species, a combination of two different killing assays (SKA and FKA), and a set of nematode mutants impaired in MRP efflux transporters. We focused on type strains due to the extensive information known, as many Bcc genomes have been completely sequenced and more will be soon become available. To define Bcc virulence we established a VR scheme, based on the percentage of surviving worms. Both nematocidal assays revealed different pathogenicity profiles for the Bcc species. Strains with high score in the VR system were able to accumulate in the nematodes intestine and produce virulence factors, on SKA and FKA, respectively. Only Bcc CF isolates accumulate within worms, an observation that correlates well with the apparent differences in virulence factors between environmental and CF isolates. This VR scheme was applied to profile Bcc pathogenesis in seven MRP impaired C. elegans mutants. MRPs are implicated in distinct nematode cellular processes: MRP1 is involved in heavy metal tolerance and ivermectine resistance [42,43]; MRP4 is central in early-stage differentiation ; MRP5 acts as a fundamental heme exporter into embryonic development . Results showed increased nematode mortality for several C. elegans mutants grown in the presence of specific Bcc strains compared to WT nematodes. In particular mrp-2 and mrp-5 were the most susceptible mutants with increased mortality respectively in 13 and 11 different Bcc strains in the two assays, suggesting an active role of these two efflux transporters in host defense. However strain mpr-5 was tested only in heterozygosis and this could have affected survival rate. Cluster analysis consistently grouped and separated mrp-3 and mrp-4 mutants in both assays from the other MRP-phenotypes. This pattern suggested different substrate specificity for these MRP transporters. To further explore the role of MRP transporters in host defense, inhibitor experiments were carried out on a selected panel of the five most "infectious" Bcc strains against the MRP knock-out mutants (B. ambifaria, B. arboris, B. cepacia, B. dolosa, B. pyrrocinia). These strains were tested against the WT nematodes in the presence of three well-characterized MRP-inhibitors, with a broad inhibitory activity against MRP transporters . These results suggested that chemically disabling of the MRPs resulted in increased C. elegans susceptibility to Bcc strains. The use of mometasone and lasalocid in the infection system increased killing rate when incubated with B. cepacia and B. dolosa, while verapamil showed a mild effect for B. arboris.
In conclusion, this study provided tools to correlate microbial pathogenicity with the host transporters, and highlighted specific efflux systems with a central role in Bcc virulence.
It is worth noting that MRPs share components of a conserved activation mechanism with the Cystic Fibrosis Transmembrane conductance Regulator (CFTR)[57,58]. Therefore, identification of bacterial signalling molecules with substrate specificity in recognizing MRPs CFRT-like efflux transporters involved in host response could be a starting point for the development of novel therapeutic strategies.
S1 Fig. Bcc strain growth in the presence of inhibitors.
For the Bcc strain growth curves in the presence of inhibitors, one single colony of each Bcc strain was placed in a tube containing 3 mL of LB broth. The tubes were then incubated at 37°C overnight in agitation. The overnight cultures were used to inoculate 250 mL flasks containing 50 mL of LB broth plus the inhibitors at an initial concentration of 0.01 OD600/mL. For each strain, a set of 5 flasks was employed: 1) Verapamile 100 μM; 2) Mometasone 100 μM; 3) Lasalocid 500 nM; 4) DMSO 0.5% v/v; 5) control (no inhibitor or DMSO). The flasks were incubated at 37°C in agitation at 220 rpm. Bacterial growth was monitored following OD600 for 36 hours every 2 hours. The experiments were performed in duplicate and the data reported represent mean values. Error bars were omitted for clarity. Results proved that the inhibitors did not interfere with Bcc growth at the concentration used in our assays, as the growth curves obtained for each strain are very similar with no viable effect in growth by any inhibitor.
Nematode strains used in this work were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). Burkholderia cepacia complex strains, used in this work, were kindly provided by Prof. Peter Vandamme, University of Gent, Belgium.
This work was supported by the EU-KBBE 2012–2016 project PharmaSea, grant N° 312184.
Elena Perrin is financially supported by a “Fondazione Adriano Buzzati-Traverso” fellowship.
Conceived and designed the experiments: PT EDS FB GT DdP. Performed the experiments: PT MV DdP. Analyzed the data: PT EP IM RF EDS FB GT MLT EP RS CP DdP. Contributed reagents/materials/analysis tools: EDS DdP. Wrote the paper: PT EP IM RF EDS FB GT MLT EP RS CP DdP.
- 1. Compant S NJ, Coenye T, Clement C, Ait Barka E (2008) Diversity and occurrence of Burkholderia spp. in the natural environment. FEMS Microbiol Rev 32(4): 607–626. pmid:18422616
- 2. Coenye T, Vandamme P (2003) Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ Microbiol 5: 719–729. pmid:12919407
- 3. Peeters C, Zlosnik JE, Spilker T, Hird TJ, LiPuma JJ, Vandamme P (2013) Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere. Syst Appl Microbiol 36: 483–489. pmid:23867250
- 4. Mahenthiralingam E, Urban TA, Goldberg JB (2005) The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3: 144–156. pmid:15643431
- 5. De Smet B, Mayo M, Peeters C, Zlosnik JE, Spilker T, Hird TJ, et al. (2015) Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources. Int J Syst Evol Microbiol 65: 2265–2271. pmid:25872960
- 6. Ramsay KA, Butler CA, Paynter S, Ware RS, Kidd TJ, Wainwright CE, et al. (2013) Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis. J Clin Microbiol 51: 3975–3980. pmid:24048536
- 7. Rose H, Baldwin A, Dowson CG, Mahenthiralingam E (2009) Biocide susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother 63: 502–510. pmid:19153076
- 8. Nash EF, Thomas A, Whitmill R, Rashid R, Barker B, Rayner RJ, et al. (2010) "Cepacia syndrome" associated with Burkholderia cepacia (genomovar I) infection in an adolescent with cystic fibrosis. Pediatr Pulmonol.
- 9. Bazzini S, Udine C, Riccardi G (2011) Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium. Appl Microbiol Biotechnol 92: 887–895. pmid:21997606
- 10. Drevinek P, Mahenthiralingam E (2010) Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect 16: 821–830. pmid:20880411
- 11. Fallon JP, Reeves EP, Kavanagh K (2011) The Aspergillus fumigatus toxin fumagillin suppresses the immune response of Galleria mellonella larvae by inhibiting the action of haemocytes. Microbiology 157: 1481–1488. pmid:21349977
- 12. Lionakis MS (2011) Drosophila and Galleria insect model hosts: new tools for the study of fungal virulence, pharmacology and immunology. Virulence 2: 521–527. pmid:22186764
- 13. Abebe E, Abebe-Akele F, Morrison J, Cooper V, Thomas WK (2011) An insect pathogenic symbiosis between a Caenorhabditis and Serratia. Virulence 2: 158–161. pmid:21389770
- 14. Olsen RJ, Watkins ME, Cantu CC, Beres SB, Musser JM (2011) Virulence of serotype M3 Group A Streptococcus strains in wax worms (Galleria mellonella larvae). Virulence 2: 111–119. pmid:21258213
- 15. Uehlinger S, Schwager S, Bernier SP, Riedel K, Nguyen DT, Sokol PA, et al. (2009) Identification of specific and universal virulence factors in Burkholderia cenocepacia strains by using multiple infection hosts. Infect Immun 77: 4102–4110. pmid:19528212
- 16. Schwager S, Agnoli K, Kothe M, Feldmann F, Givskov M, Carlier A et al. (2013) Identification of Burkholderia cenocepacia strain H111 virulence factors using nonmammalian infection hosts. Infect Immun 81: 143–153. pmid:23090963
- 17. Kurz CL, Chauvet S, Andres E, Aurouze M, Vallet I, Michel GP et al. (2003) Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. EMBO J 22: 1451–1460. pmid:12660152
- 18. Mylonakis E, Ausubel FM, Tang RJ, Calderwood SB (2003) The art of serendipity: killing of Caenorhabditis elegans by human pathogens as a model of bacterial and fungal pathogenesis. Expert Rev Anti Infect Ther 1: 167–173. pmid:15482109
- 19. Tan MW, Ausubel FM (2000) Caenorhabditis elegans: a model genetic host to study Pseudomonas aeruginosa pathogenesis. Curr Opin Microbiol 3: 29–34. pmid:10679415
- 20. Bhatt S, Anyanful A, Kalman D (2011) CsrA and TnaB coregulate tryptophanase activity to promote exotoxin-induced killing of Caenorhabditis elegans by enteropathogenic Escherichia coli. J Bacteriol 193: 4516–4522. pmid:21705596
- 21. Lee SH, Ooi SK, Mahadi NM, Tan MW, Nathan S (2011) Complete killing of Caenorhabditis elegans by Burkholderia pseudomallei is dependent on prolonged direct association with the viable pathogen. PLoS One 6: e16707. pmid:21408228
- 22. O'Quinn AL, Wiegand EM, Jeddeloh JA (2001) Burkholderia pseudomallei kills the nematode Caenorhabditis elegans using an endotoxin-mediated paralysis. Cell Microbiol 3: 381–393. pmid:11422081
- 23. Lee SH, Wong RR, Chin CY, Lim TY, Eng SA, Kong C et al. (2013) Burkholderia pseudomallei suppresses Caenorhabditis elegans immunity by specific degradation of a GATA transcription factor. Proc Natl Acad Sci U S A.
- 24. Huber B, Feldmann F, Kothe M, Vandamme P, Wopperer J, Riedel K, et al. (2004) Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans. Infect Immun 72: 7220–7230. pmid:15557647
- 25. Kothe M, Antl M, Huber B, Stoecker K, Ebrecht D, Steinmetz I, et al. (2003) Killing of Caenorhabditis elegans by Burkholderia cepacia is controlled by the cep quorum-sensing system. Cell Microbiol 5: 343–351. pmid:12713492
- 26. Sousa SA, Ramos CG, Leitao JH (2011) Burkholderia cepacia Complex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants. Int J Microbiol 2011.
- 27. Tegos GP, Haynes MK, Schweizer HP (2012) Dissecting novel virulent determinants in the Burkholderia cepacia complex. Virulence 3: 234–237. pmid:22546904
- 28. O'Grady EP, Viteri DF, Sokol PA (2012) A unique regulator contributes to quorum sensing and virulence in Burkholderia cenocepacia. PLoS One 7: e37611. pmid:22624054
- 29. Cooper VS, Carlson WA, Lipuma JJ (2009) Susceptibility of Caenorhabditis elegans to Burkholderia infection depends on prior diet and secreted bacterial attractants. PLoS One 4: e7961. pmid:19956737
- 30. Cardona ST, Wopperer J, Eberl L, Valvano MA (2005) Diverse pathogenicity of Burkholderia cepacia complex strains in the Caenorhabditis elegans host model. FEMS Microbiol Lett 250: 97–104. pmid:16043310
- 31. Springman AC, Jacobs JL, Somvanshi VS, Sundin GW, Mulks MH, Whittam TS, et al. (2009) Genetic diversity and multihost pathogenicity of clinical and environmental strains of Burkholderia cenocepacia. Appl Environ Microbiol 75: 5250–5260. pmid:19542323
- 32. Sousa SA, Ramos CG, Moreira LM, Leitao JH (2010) The hfq gene is required for stress resistance and full virulence of Burkholderia cepacia to the nematode Caenorhabditis elegans. Microbiology 156: 896–908.pmid:19942656
- 33. Markey KM, Glendinning KJ, Morgan JA, Hart CA, Winstanley C (2006) Caenorhabditis elegans killing assay as an infection model to study the role of type III secretion in Burkholderia cenocepacia. J Med Microbiol 55: 967–969. pmid:16772429
- 34. Martinez JL, Sanchez MB, Martinez-Solano L, Hernandez A, Garmendia L, Fajardo A, et al. (2009) Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev 33: 430–449. pmid:19207745
- 35. Buroni S, Pasca MR, Flannagan RS, Bazzini S, Milano A, Bertani I, et al. (2009) Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol 9: 200. pmid:19761586
- 36. Feinbaum RL, Urbach JM, Liberati NT, Djonovic S, Adonizio A, Carvunis AR, et al. (2012) Genome-wide identification of Pseudomonas aeruginosa virulence-related genes using a Caenorhabditis elegans infection model. PLoS Pathog 8: e1002813. pmid:22911607
- 37. Ooi SK, Lim TY, Lee SH, Nathan S (2012) Burkholderia pseudomallei kills Caenorhabditis elegans through virulence mechanisms distinct from intestinal lumen colonization. Virulence 3: 485–496. pmid:23076282
- 38. Harland DN, Dassa E, Titball RW, Brown KA, Atkins HS (2007) ATP-binding cassette systems in Burkholderia pseudomallei and Burkholderia mallei. BMC Genomics 8: 83. pmid:17391530
- 39. Dean M, Rzhetsky A, Allikmets R (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11: 1156–1166. pmid:11435397
- 40. Sheps JA, Ralph S, Zhao Z, Baillie DL, Ling V (2004) The ABC transporter gene family of Caenorhabditis elegans has implications for the evolutionary dynamics of multidrug resistance in eukaryotes. Genome Biol 5: R15. pmid:15003118
- 41. Rees D, Johnson E, Lewinson O (2009) ABC transporters: the power to change. Nat Rev Mol Cell Biol 10: 218–227. pmid:19234479
- 42. James CE, Davey MW (2009) Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans. Int J Parasitol 39: 213–220. pmid:18708066
- 43. Yan R, Urdaneta-Marquez L, Keller K, James CE, Davey MW, Prichard RK (2012) The role of several ABC transporter genes in ivermectin resistance in Caenorhabditis elegans. Vet Parasitol 190: 519–529. pmid:22840641
- 44. Kurz CL, Shapira M, Chen K, Baillie DL, Tan MW (2007) Caenorhabditis elegans pgp-5 is involved in resistance to bacterial infection and heavy metal and its regulation requires TIR-1 and a p38 map kinase cascade. Biochem Biophys Res Commun 363: 438–443. pmid:17888400
- 45. Brenner S (1974) The genetics of Caenorhabdits elegans. Genetics 77: 71–94. pmid:4366476
- 46. Stiernagle T (2006) Maintenance of C. elegans WormBook,The C elegans Research Community.
- 47. Wopperer J, Cardona ST, Huber B, Jacobi CA, Valvano MA, Eberl L (2006) A quorum-quenching approach to investigate the conservation of quorum-sensing-regulated functions within the Burkholderia cepacia complex. Appl Environ Microbiol 72: 1579–1587. pmid:16461713
- 48. Pirone L, Bragonzi A, Farcomeni A, Paroni M, Auriche C, Conese M, et al. (2008) Burkholderia cenocepacia strains isolated from cystic fibrosis patients are apparently more invasive and more virulent than rhizosphere strains. Environ Microbiol 10: 2773–2784. pmid:18643926
- 49. Thomson EL, Dennis JJ (2012) A Burkholderia cepacia complex non-ribosomal peptide-synthesized toxin is hemolytic and required for full virulence. Virulence 3: 286–298. pmid:22546908
- 50. Lu SE, Novak J, Austin FW, Gu G, Ellis D, Kirk M, et al. (2009) Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans. Biochemistry 48: 8312–8321. pmid:19673482
- 51. Strouse JJ, Ivnitski-Steele I, Waller A, Young SM, Perez D, Evangelisti AM, et al. (2013) Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters. Anal Biochem 437: 77–87. pmid:23470221
- 52. Horger KS, Liu H, Rao DK, Shukla S, Sept D, Ambudkar SV, et al. (2015) Hydrogel-assisted functional reconstitution of human P-glycoprotein (ABCB1) in giant liposomes. Biochim Biophys Acta 1848: 643–653. pmid:25450342
- 53. Eilers M, Roy U, Mondal D (2008) MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells. Exp Biol Med (Maywood) 233: 1149–1160.
- 54. Ardelli BF, Prichard RK (2013) Inhibition of P-glycoprotein enhances sensitivity of Caenorhabditis elegans to ivermectin. Vet Parasitol 191: 264–275. pmid:23062691
- 55. Currie E, King B, Lawrenson AL, Schroeder LK, Kershner AM, Hermann GJ (2007) Role of the Caenorhabditis elegans multidrug resistance gene, mrp-4, in gut granule differentiation. Genetics 177: 1569–1582. pmid:17947407
- 56. Korolnek T, Zhang J, Beardsley S, Scheffer GL, Hamza I (2014) Control of metazoan heme homeostasis by a conserved multidrug resistance protein. Cell Metab 19: 1008–1019. pmid:24836561
- 57. Wei S, Roessler BC, Chauvet S, Guo J, Hartman JLt, Kirk KL (2014) Conserved allosteric hot spots in the transmembrane domains of cystic fibrosis transmembrane conductance regulator (CFTR) channels and multidrug resistance protein (MRP) pumps. J Biol Chem 289: 19942–19957. pmid:24876383
- 58. Keppler D (2011) Multidrug resistance proteins (MRPs, ABCCs): importance for pathophysiology and drug therapy. Handb Exp Pharmacol: 299–323. pmid:21103974